Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Afegostat Tartrate in Type 1 Gaucher Disease
NCT00446550Phase 2Completed
- Sponsor
- Amicus Therapeutics
- Start
- Jun 2008
- Primary completion
- Aug 2009
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of Afegostat in Gaucher disease type 1 (GD1), sponsored by Amicus Therapeutics. Started Jun 2008; status: completed.
02
Drugs
Afegostat
03
Conditions
Gaucher disease type 1 (GD1)
Beyond the preview
Go deeper on NCT00446550.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00446550.